Royalty Pharma plc Class A Ordinary Shares

$53.96
USD
Last updated on --.
24h volume3.08M
24h highest54.6800 USD
24h lowest53.5000 USD
24h Price movement+0.20%

RPRX recent prices

24 Hours
+0.20%+$0.105
30 days
+10.03%+$4.970
60 days
+17.55%+$8.140
90 days
+17.96%+$8.300

Key data

Previous close53.8600 USD
Market cap23.52B USD
Volume3.08M
P/E ratio28.430000
Dividend yield (TTM)0.03%
Dividend amount0.23500 USD
Next ex-dividend dateMay 15, 2026
Next payment dateJun 10, 2026
EPS diluted (TTM)1.8700 USD
Net income (FY)1.36B USD
Revenue (FY)2.44B USD
Last report dateMay 6, 2026

About Royalty Pharma plc Class A Ordinary Shares

PHARMACEUTICAL PREPARATIONS
HeadquartersNEW YORK
Employees (FY)100.00
Revenue per employee (FY)24.41M USD
Net income per employee (FY)13.59M USD
Listed onNasdaq
Official website

RPRX conversion tables

RPRXRPRX
USDUSD
0.5 RPRX26.98 USD
1 RPRX53.96 USD
5 RPRX269.82 USD
10 RPRX539.65 USD
USDUSD
RPRXRPRX
0.5 USD0.0092653 RPRX
1 USD0.018531 RPRX
5 USD0.092653 RPRX
10 USD0.18531 RPRX

FAQ

RPRX is trading at $53.96, +0.20% over the last 24 hours. Track live moves on the price chart at the top of this page.
The RPRX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. RPRX is currently trading at $53.96, +0.20% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on RPRX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. RPRX's P/E ratio is currently 28.430000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from RPRX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against RPRX's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Royalty Pharma plc Class A Ordinary Shares's market cap is currently 23.52B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume3.08M
24h highest54.6800 USD
24h lowest53.5000 USD
24h Price movement+0.20%
RPRXRPRX
USDUSD
Start trade with RPRX Perpetual